Delivery Order SPE2DB22D9207-SPE2DB24FH4TX
- Not listed
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at thirty-seven thousand eight hundred fifty-eight dollars by the Defense Logistics Agency to supply NUCALA 100 MG/ML SYRINGEML. This delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a potential value of up to five million dollars through December 2025. As a woman-owned...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at fifty-six thousand, seven hundred eighty-seven dollars ($56,787) by the Defense Logistics Agency to provide NUCALA 100 MG/ML SYRINGEML. This delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceutical items and medical products with a potential value of up to five million dollars ($5,000,000) through...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $18,929 by the Defense Logistics Agency to supply NUCALA 100 MG/ML SYRINGEML. This order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to provide pharmaceuticals and medical supplies with a total potential value of up to $5 million through December 2025. As a woman-owned small business, DMS Pharmaceutical Group will deliver the...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at $22,714.80 by the Defense Logistics Agency to provide NUCALA 100 MG/ML SYRINGEML. The delivery order was issued against DMS Pharmaceutical Group's existing indefinite delivery contract with the Defense Logistics Agency to supply pharmaceutical items and medical products with a potential value of up to $5 million through December 2025. As a woman-owned small business and woman-owned business, DMS...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $3,785.80 under an indefinite delivery contract with the Defense Logistics Agency to supply NUCALA 100 MG/ML auto-injectors. As a woman-owned small business, DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides prescription drugs and medical supplies to support military treatment facilities worldwide. The delivery order is for provision of the specified pharmaceutical item to DLA Troop...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at eleven thousand three hundred fifty-seven dollars and forty cents ($11,357.40) by the Defense Logistics Agency Troop Support Medical. The delivery order is for NUCALA 100 MG/ML SYRINGEML to fulfill requirements under the agency's indefinite delivery contract with DMS Pharmaceutical Group. This contract provides pharmaceutical items and medical supplies with a potential value of up to five million dollars...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $3,785.80 under an indefinite delivery contract with the Defense Logistics Agency. The delivery order is for the supply of 4562675402 NUCALA 100 MG/ML auto-injectors to fulfill requirements at DLA Troop Support Medical facilities. As a woman-owned small business, DMS Pharmaceutical Group provides a wide range of pharmaceutical and medical products in support of the Defense Logistics Agency's global operations....
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at three thousand seven hundred eighty-five dollars and eighty cents ($3,785.80) by the Defense Logistics Agency Troop Support Medical. This delivery order was issued against an indefinite delivery contract held by DMS Pharmaceutical Group to supply pharmaceutical items and medical products to military treatment facilities supported by the Defense Logistics Agency. Under this delivery order, DMS...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at five thousand six hundred seventy-eight dollars and seventy cents ($5,678.70) by the Defense Logistics Agency Troop Support Medical. This order was issued against DMS Pharmaceutical Group's indefinite delivery contract to supply pharmaceutical items and medical products to military treatment facilities supported by the Defense Logistics Agency. Under this delivery order, DMS Pharmaceutical Group will...
- DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order valued at eleven thousand three hundred fifty-seven dollars and forty cents ($11,357.40) by the Defense Logistics Agency Troop Support Medical. The delivery order is for the supply of 4562879717 NUCALA 100 MG/ML auto-injectors to fulfill requirements through November 2023. DMS Pharmaceutical Group is a woman-owned small business and woman-owned business pharmaceutical wholesaler that currently holds an indefinite...
- SPE2DB22D9207Indefinite Delivery Contract
- SPE2DB22D9207-SPE2DB24FH4TXDelivery Order
DMS Pharmaceutical Group Inc. has been awarded a firm fixed price delivery order for $3,785.80 under an indefinite delivery contract with the Defense Logistics Agency to supply NUCALA 100 MG/ML SYRINGEML. As a woman owned small business and woman owned business, DMS Pharmaceutical Group is a leading pharmaceutical wholesaler that provides prescription and over-the-counter drug supplies to the Department of Defense through numerous contracts and delivery orders. This delivery order is issued against an existing indefinite delivery contract with the Defense Logistics Agency to provide pharmaceutical items and medical supplies with a potential value of up to $5 million through December 2025. Performance will be completed by November 6, 2023 at the prime contractor's place of performance in Park Ridge, Illinois. No set-aside designation was applied to this award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.8k | 11/3/23 |